SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

SANLAM ADR EACH REPR 2 SHS (OTCMKTS:SLLDY) was a notable outperformer during Tuesday’s trading session surging by 11% on relatively high volumes, which were 1.3 times the 30 day average turnover. Bears continue to be in total control as Sanlam Adre continues to form lower tops and lower bottoms indicative of the strong bearish momentum. The stock continues to trade below all moving averages. Many traders believe the price action seen during Tuesday’s trading session was a mere profit taking move.The MACD oscillators are showing signs no signs of a bullish reversal, which is considered to be a huge negative.

SLLDY

SANLAM ADR EACH REPR 2 SHS (OTCMKTS:SLLDY) announced interim results for 2015 following a good performance in 2014. As per the reports, the net growth in business volumes in this year remains intact at 22% to touch a whopping figure of R100 billion.

Other Highlights For The Year

If taken into account all the financial businesses, one can notice that net results per share from all of them put together have increased 5% on YOY basis. At the same time, the return on Group Equity Value per share for the year increased 13 percent YOY. The group equity value per share for the year was R47,53. Normalized headline earnings per share were up 4% in the year.

The net value of new covered business reached to R655 million, 5% higher than the numbers reported in 2014. Although Sanlam performed up to expectations in most of the business fields, its margin in new covered business was 2.66% for the year against last year’s 2.68 percent. The company witnessed a net fund inflow of R7 billion during the year.

It reported a total of R2.5 billion unallocated discretionary capital and CAR cover for its life insurance entity of 4.8 times for the year.

Expansion in African Subcontinent

Before announcing the interim results for the year, Sanlam announced an initiative to increase its footprint in Africa. As per the reports, Sanlam and its subsidiary Santam announced their agreements to acquire 30% stake in the Saham Finances S.A., insurance business of Saham Group. Sanlam and Santam have paid around $375 million to acquire this Morocco-based business, which is expected to help them expand in Africa.

The Saham Group already owns 62.5% shares of Saham Finances, and this step will help it strengthen its stake-holding position in the company. The senior management of the company looks forward to taking more such steps in the future to expand in different regions.

SHARE
Previous articlePharmacyte Biotech Inc (OTCMKTS:PMCB) Appoints Hans-Peter Hammes To Its Scientific Advisory Board
Next articleSoligenix Inc (OTCBB:SNGX) Announces 3Q2015 Highlights, Revenues Increase To $3.9 Million
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.